Literature DB >> 508558

Plasma Xa inhibitory activities and plasma concentrations of norgestrel and ethinyloestradiol in women on oral contraceptive steroids.

D J Back, M Bates, M W Burke, A M Breckenridge, F E Crawford, M MacIver, M L Orme, P H Rowe, E Smith, S Webster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508558      PMCID: PMC1429815          DOI: 10.1111/j.1365-2125.1979.tb01034.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Oral contraceptives and low antithrombin-3 activity.

Authors:  E von Kaulla; K N von Kaulla
Journal:  Lancet       Date:  1970-01-03       Impact factor: 79.321

2.  Antithrombin 3, antifactor Xa and heparin.

Authors:  R Biggs; K W Denson; N Akman; R Borrett; M Hadden
Journal:  Br J Haematol       Date:  1970-09       Impact factor: 6.998

3.  Effect of heparin on the neutralization of factor Xa and thrombin by the plasma alpha-2-globulin inhibitor.

Authors:  E T Yin
Journal:  Thromb Diath Haemorrh       Date:  1975-02-28

4.  Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis.

Authors:  S Sagar; J D Stamatakis; D P Thomas; V V Kakkar
Journal:  Lancet       Date:  1976-03-06       Impact factor: 79.321

5.  Postoperative thromboembolism and the use of oral contraceptives.

Authors:  M P Vessey; R Doll; A S Fairbairn; G Glober
Journal:  Br Med J       Date:  1970-07-18

6.  Estrogen-containing oral contraceptive agents. A basis for their thrombogenicity.

Authors:  S Wessler; S N Gitel; L S Wan; B S Pasternack
Journal:  JAMA       Date:  1976-11-08       Impact factor: 56.272

  6 in total
  1 in total

Review 1.  Clinical pharmacokinetics of oral contraceptive steroids.

Authors:  M L Orme; D J Back; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.